,Set,NGenes,Direction,PValue,FDR
1,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,37,Down,5.15580108092753e-05,0.0236539008588715
2,WP_CREATINE_PATHWAY,2,Down,5.75520702162323e-05,0.0236539008588715
3,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Down,0.000489255524157225,0.119173950105727
4,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,15,Down,0.000579921898324703,0.119173950105727
5,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,23,Up,0.00089967071319152,0.147905865248686
6,WP_POSTCOVID_NEUROINFLAMMATION,12,Down,0.00131946866497135,0.174994694003652
7,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,78,Down,0.00149022245501894,0.174994694003652
8,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.00193868918451985,0.199200313709415
9,WP_GASTRIC_CANCER_NETWORK_1,18,Up,0.00246122098434064,0.210239888044308
10,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,24,Down,0.00277329666645873,0.210239888044308
11,WP_BURN_WOUND_HEALING,61,Down,0.00303456256805824,0.210239888044308
12,WP_ARYLAMINE_METABOLISM,1,Up,0.00340649528116173,0.210239888044308
13,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.00366388909619146,0.210239888044308
14,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,4,Up,0.00417923088926988,0.210239888044308
15,WP_SPINAL_CORD_INJURY,66,Down,0.00424730656057956,0.210239888044308
16,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.00429239568243443,0.210239888044308
17,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Up,0.00434802688169493,0.210239888044308
18,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.00514440063707819,0.217473324673301
19,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.00540911564914488,0.217473324673301
20,WP_ZINC_HOMEOSTASIS,22,Up,0.00550148978879012,0.217473324673301
21,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.00555588785661717,0.217473324673301
22,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Down,0.00705118996620875,0.261947171868194
23,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.00747913746276562,0.261947171868194
24,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.00764809260929033,0.261947171868194
25,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.0080075884116521,0.263289506975121
26,WP_GPCRS_CLASS_B_SECRETINLIKE,5,Down,0.00918573420959002,0.277114585785147
27,WP_PROLACTIN_SIGNALING,69,Down,0.00920112929061945,0.277114585785147
28,WP_ERBB_SIGNALING,69,Down,0.00979030270973853,0.277114585785147
29,WP_IL26_SIGNALING,31,Down,0.0100268463864502,0.277114585785147
30,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.0106368664615364,0.277114585785147
31,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,9,Down,0.0107800994316347,0.277114585785147
32,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,13,Down,0.0110924305383928,0.277114585785147
33,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.0118988986372795,0.277114585785147
34,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.0121252768980718,0.277114585785147
35,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.012408296385716,0.277114585785147
36,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.0124440008331902,0.277114585785147
37,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.012473527584003,0.277114585785147
38,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.0129514214441064,0.280159695448827
39,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.0136231818288789,0.286765167731401
40,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.013954509378657,0.286765167731401
41,WP_DOPAMINE_METABOLISM,7,Up,0.0153747700735811,0.30332782061503
42,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.0154985017832497,0.30332782061503
43,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.0165126429728121,0.313090689312781
44,WP_VITAMIN_B12_METABOLISM,25,Down,0.0167591123233118,0.313090689312781
45,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.0174106499595469,0.318034539261057
46,WP_OREXIN_RECEPTOR_PATHWAY,118,Down,0.0186303082310609,0.327059168800887
47,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.0189530121993613,0.327059168800887
48,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,28,Down,0.019371741765905,0.327059168800887
49,WP_GPCRS_OTHER,15,Down,0.0195669541274194,0.327059168800887
50,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,106,Down,0.0198941100243849,0.327059168800887
51,WP_ASPIRIN_AND_MIRNAS,8,Down,0.0206211599096419,0.332364577367169
52,WP_NETRINUNC5B_SIGNALING,35,Down,0.0212239001550349,0.335500883219974
53,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.0221949548207606,0.337359444075525
54,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.0222044891137262,0.337359444075525
55,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.0225727121948344,0.337359444075525
56,WP_INSULIN_SIGNALING,132,Down,0.0252433712863923,0.366519852998501
57,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.0254156102444216,0.366519852998501
58,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.0268694370229623,0.374972508912307
59,WP_MACROPHAGE_MARKERS,8,Down,0.0269140851895695,0.374972508912307
60,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.0281800275940509,0.382097660184434
61,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.0283551791621052,0.382097660184434
62,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.029126824174178,0.386165314051198
63,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,38,Up,0.0313464575478288,0.406074152260992
64,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.0316164790081551,0.406074152260992
65,WP_PROSTAGLANDIN_SIGNALING,22,Down,0.032825143080596,0.412143889944565
66,WP_LUNG_PATHOLOGY_OF_COVID19,15,Down,0.0337207503695524,0.412143889944565
67,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,23,Up,0.0340908262792332,0.412143889944565
68,WP_GLYOXYLATE_METABOLISM,5,Up,0.0340946283652438,0.412143889944565
69,WP_IRON_METABOLISM_IN_PLACENTA,8,Down,0.0348952974430999,0.415709195626495
70,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.0362551815571603,0.425739417714082
71,WP_MAPK_SIGNALING,165,Down,0.0375630057327965,0.434884376230404
72,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.0391967941573618,0.447496733296547
73,WP_MAPK_CASCADE,30,Down,0.0406372578737027,0.457586657153201
74,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.0413314629484107,0.459114358697211
75,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Down,0.0422070822129247,0.460783517536091
76,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Up,0.0426028556359403,0.460783517536091
77,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.0435699306171454,0.465123155419396
78,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.0442019548345192,0.465820600948395
79,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.0456971334430977,0.470208565875682
80,WP_TAMOXIFEN_METABOLISM,2,Up,0.0457623908394824,0.470208565875682
81,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.0467122777653552,0.474043115100271
82,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,20,Down,0.0492123404216076,0.486800437666662
83,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Down,0.0497156977888509,0.486800437666662
84,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.049916659389492,0.486800437666662
85,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.0511565049190086,0.486800437666662
86,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.0511958653039073,0.486800437666662
87,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.0528491251128072,0.486800437666662
88,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.0536908383294161,0.486800437666662
89,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.0538553545955971,0.486800437666662
90,WP_CHEMOKINE_SIGNALING,109,Down,0.0543087346345741,0.486800437666662
91,WP_GPR40_PATHWAY,10,Down,0.054384181435908,0.486800437666662
92,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.0544837472814268,0.486800437666662
93,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.0554504812058298,0.490110704851528
94,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Down,0.0570186978129578,0.498610314917567
95,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.0599142320366315,0.514304523686392
96,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.0609623954563479,0.514304523686392
97,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.0619328440506214,0.514304523686392
98,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,24,Down,0.062615122565991,0.514304523686392
99,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Down,0.0644133033619121,0.514304523686392
100,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.0647772483147821,0.514304523686392
101,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.0657551424440378,0.514304523686392
102,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.0658564660781589,0.514304523686392
103,WP_RANKLRANK_SIGNALING,48,Down,0.0667676807271289,0.514304523686392
104,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.066891598122327,0.514304523686392
105,WP_IL1_SIGNALING,54,Down,0.0669223194032733,0.514304523686392
106,WP_FOLATE_METABOLISM,38,Down,0.0672342344068102,0.514304523686392
107,WP_NEURAL_CREST_DIFFERENTIATION,41,Down,0.0674742185983304,0.514304523686392
108,WP_PDGF_PATHWAY,37,Down,0.0675728571266792,0.514304523686392
109,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.0696714508813937,0.517918384321983
110,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,48,Down,0.0703700976748718,0.517918384321983
111,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.0709498743645699,0.517918384321983
112,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Down,0.0710994503445097,0.517918384321983
113,WP_B_CELL_RECEPTOR_SIGNALING,87,Down,0.0723890790493514,0.517918384321983
114,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Down,0.0724092386977317,0.517918384321983
115,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,87,Down,0.0724581681229052,0.517918384321983
116,WP_KIT_RECEPTOR_SIGNALING,52,Down,0.0735865926371384,0.519981005486888
117,WP_HYPERTROPHY_MODEL,13,Down,0.0740118949415644,0.519981005486888
118,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.0770549689238035,0.525819732190509
119,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.0774886329569826,0.525819732190509
120,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.0778251311654338,0.525819732190509
121,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.078044622273277,0.525819732190509
122,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.0785719017022613,0.525819732190509
123,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.0792651129577242,0.525819732190509
124,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.080258749078511,0.525819732190509
125,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.0805161244359255,0.525819732190509
126,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.0806001049343115,0.525819732190509
127,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.0881168141478067,0.566843652185614
128,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,50,Down,0.088876202981614,0.566843652185614
129,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,13,Down,0.0889572154889832,0.566843652185614
130,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,37,Up,0.0927275373698234,0.586323351676883
131,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.0941406610565139,0.588997169521431
132,WP_MONOAMINE_TRANSPORT,12,Down,0.0952845524059563,0.588997169521431
133,WP_KETOGENESIS_AND_KETOLYSIS,6,Up,0.095300028645195,0.588997169521431
134,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,93,Down,0.0961793389952242,0.589995646672196
135,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,64,Down,0.0969786500655366,0.590492224843489
136,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Down,0.098745220674108,0.591372282650587
137,WP_EGFEGFR_SIGNALING,141,Down,0.0989107654048988,0.591372282650587
138,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.100361654261082,0.591372282650587
139,WP_JOUBERT_SYNDROME,72,Up,0.101194513262966,0.591372282650587
140,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Down,0.101451806520079,0.591372282650587
141,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.102092940049763,0.591372282650587
142,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Down,0.102159202112388,0.591372282650587
143,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,74,Down,0.10406922169235,0.598216085532249
144,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,49,Down,0.107122070790836,0.603120970565288
145,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.107211531281034,0.603120970565288
146,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.107560233261791,0.603120970565288
147,WP_GABA_RECEPTOR_SIGNALING,10,Down,0.107857399845617,0.603120970565288
148,WP_NRF2ARE_REGULATION,20,Up,0.109454228213409,0.60400324136458
149,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.109484772461463,0.60400324136458
150,WP_RETT_SYNDROME,33,Down,0.114150088668807,0.625542485905063
151,WP_BENZENE_METABOLISM,4,Up,0.116440053266267,0.628456932049544
152,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.116956637557247,0.628456932049544
153,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.116975560344988,0.628456932049544
154,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,26,Up,0.118791756142961,0.630601008718476
155,WP_REGULATION_OF_ACTIN_CYTOSKELETON,92,Down,0.119349553848844,0.630601008718476
156,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Up,0.121106048665377,0.630601008718476
157,WP_ENDOCHONDRAL_OSSIFICATION,26,Up,0.121210412868028,0.630601008718476
158,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Up,0.121210412868028,0.630601008718476
159,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,61,Down,0.12272598559181,0.634470189663322
160,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Down,0.123947087009321,0.636778159510386
161,WP_NEUROINFLAMMATION,10,Down,0.128845865286335,0.654626025367866
162,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.129812515211532,0.654626025367866
163,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.130215104448713,0.654626025367866
164,WP_EICOSANOID_SYNTHESIS,14,Down,0.130606652263175,0.654626025367866
165,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.133680361118497,0.660590281437228
166,WP_LUNG_FIBROSIS,33,Down,0.134943558870938,0.660590281437228
167,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Up,0.135167013967955,0.660590281437228
168,WP_MEASLES_VIRUS_INFECTION,101,Up,0.135309482702955,0.660590281437228
169,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.136330419699331,0.660590281437228
170,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Down,0.138204710480089,0.660590281437228
171,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,33,Up,0.13821975617468,0.660590281437228
172,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Down,0.138225703658398,0.660590281437228
173,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.140696074739324,0.663945471370673
174,WP_SYNAPTIC_VESICLE_PATHWAY,22,Down,0.141494707938791,0.663945471370673
175,WP_ONCOSTATIN_M_SIGNALING,55,Down,0.142274217380991,0.663945471370673
176,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.142951304712552,0.663945471370673
177,WP_NRF2_PATHWAY,74,Up,0.142966360623612,0.663945471370673
178,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Down,0.145819091863774,0.673389289393385
179,WP_ADIPOGENESIS,86,Down,0.147932632921221,0.67716643297556
180,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.148476139741742,0.67716643297556
181,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.150598490405929,0.67716643297556
182,WP_BLADDER_CANCER,29,Down,0.150635972909835,0.67716643297556
183,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Up,0.150756030698938,0.67716643297556
184,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.152808619942667,0.682655899961262
185,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.15667377055382,0.686440855171336
186,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.157780623230921,0.686440855171336
187,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.160286447590313,0.686440855171336
188,WP_METHYLATION_PATHWAYS,5,Up,0.160442328454214,0.686440855171336
189,WP_PHOSPHOINOSITIDES_METABOLISM,39,Down,0.160836955797497,0.686440855171336
190,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.160947641683901,0.686440855171336
191,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.161402338612669,0.686440855171336
192,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.161589151329298,0.686440855171336
193,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.162116680723322,0.686440855171336
194,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.163492478179683,0.686440855171336
195,WP_OVARIAN_INFERTILITY,22,Down,0.163846835977748,0.686440855171336
196,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Down,0.164481761050474,0.686440855171336
197,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Up,0.164511981105539,0.686440855171336
198,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.166815246339872,0.689511540293975
199,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,46,Down,0.166925543209855,0.689511540293975
200,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.16971132321007,0.690631761142084
201,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,45,Down,0.170436517111315,0.690631761142084
202,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,16,Down,0.170808501180645,0.690631761142084
203,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.171146220415968,0.690631761142084
204,WP_EBOLA_VIRUS_INFECTION_IN_HOST,106,Down,0.171435505385801,0.690631761142084
205,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,26,Up,0.172237847973391,0.690631761142084
206,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,87,Down,0.173344593278565,0.691695415897965
207,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.175330829148437,0.692486934778644
208,WP_KREBS_CYCLE_DISORDERS,12,Up,0.175458461739223,0.692486934778644
209,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Down,0.176070279037392,0.692486934778644
210,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,11,Down,0.178534730385413,0.698835944651472
211,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.183073083091252,0.704785356128138
212,WP_PURINE_METABOLISM,10,Down,0.183682876442548,0.704785356128138
213,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.183941098831685,0.704785356128138
214,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.184672376166117,0.704785356128138
215,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.185866148403904,0.704785356128138
216,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.185884121937416,0.704785356128138
217,WP_PLEURAL_MESOTHELIOMA,256,Down,0.186446372655594,0.704785356128138
218,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.186913877902596,0.704785356128138
219,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.188403269805769,0.707145442060397
220,WP_ID_SIGNALING,12,Down,0.191138922491348,0.707145442060397
221,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.19142273325013,0.707145442060397
222,WP_AXON_GUIDANCE,38,Down,0.192204373196228,0.707145442060397
223,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,48,Down,0.192553116209215,0.707145442060397
224,WP_RETINOL_METABOLISM,6,Up,0.192840054465755,0.707145442060397
225,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.193561708593174,0.707145442060397
226,WP_SLEEP_REGULATION,11,Up,0.197205488546614,0.717103601716181
227,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,15,Down,0.200606495828082,0.717103601716181
228,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.201609946379019,0.717103601716181
229,WP_GLIOBLASTOMA_SIGNALING,68,Down,0.202087469496229,0.717103601716181
230,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.202280705707911,0.717103601716181
231,WP_ALANINE_AND_ASPARTATE_METABOLISM,6,Up,0.203175533135699,0.717103601716181
232,WP_MATRIX_METALLOPROTEINASES,8,Down,0.20440668847788,0.717103601716181
233,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,16,Up,0.205155489607066,0.717103601716181
234,WP_ALLOGRAFT_REJECTION,51,Down,0.205362724360961,0.717103601716181
235,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Down,0.206417432916927,0.717103601716181
236,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.208459185657403,0.717103601716181
237,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Down,0.208842838611415,0.717103601716181
238,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.209083562043141,0.717103601716181
239,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.210582986489329,0.717103601716181
240,WP_G13_SIGNALING,30,Down,0.210937010008359,0.717103601716181
241,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,56,Up,0.211504995055842,0.717103601716181
242,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,38,Down,0.211692669057137,0.717103601716181
243,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.213345933895977,0.717103601716181
244,WP_SULFATASE_AND_AROMATASE_PATHWAY,3,Up,0.213468730809511,0.717103601716181
245,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Up,0.213735258419056,0.717103601716181
246,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.220245725796526,0.733978325653222
247,WP_BENZOAPYRENE_METABOLISM,5,Up,0.221374677054614,0.733978325653222
248,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.222267198952129,0.733978325653222
249,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Down,0.222336500106633,0.733978325653222
250,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.224100860741251,0.736075604210985
251,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.224840665440991,0.736075604210985
252,WP_MIRNA_BIOGENESIS,6,Up,0.226162405824827,0.736075604210985
253,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.226553683534525,0.736075604210985
254,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.229064505194386,0.737452180425604
255,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.229261105376292,0.737452180425604
256,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.230375333227664,0.737452180425604
257,WP_COPPER_HOMEOSTASIS,40,Up,0.230565949354477,0.737452180425604
258,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,22,Up,0.23452439732501,0.741823827733427
259,WP_GLUCURONIDATION,7,Up,0.234577433772802,0.741823827733427
260,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Down,0.236204472995958,0.741823827733427
261,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.237186756805684,0.741823827733427
262,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,31,Down,0.237404631011054,0.741823827733427
263,WP_DRAVET_SYNDROME,15,Down,0.238439063661886,0.741823827733427
264,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.239153569522032,0.741823827733427
265,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.240545689671292,0.741823827733427
266,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.240720875416036,0.741823827733427
267,WP_COMPLEMENT_AND_COAGULATION_CASCADES,25,Up,0.243082454058885,0.741823827733427
268,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,25,Up,0.243082454058885,0.741823827733427
269,WP_GASTRIC_CANCER_NETWORK_2,26,Down,0.243724877869821,0.741823827733427
270,WP_SMALL_CELL_LUNG_CANCER,69,Down,0.243830834443446,0.741823827733427
271,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.244567223011872,0.741823827733427
272,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.247673378536514,0.748483518959611
273,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.249040003103776,0.749856712642139
274,WP_NAD_METABOLISM,12,Down,0.250820417496041,0.752461252488124
275,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.254052706450078,0.756048772568636
276,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,18,Down,0.254499847355951,0.756048772568636
277,WP_ESTROGEN_METABOLISM_WP5276,9,Up,0.254775559612545,0.756048772568636
278,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.256622123131057,0.756909410282568
279,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.257521594036779,0.756909410282568
280,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.260464134728296,0.756909410282568
281,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.260803909216661,0.756909410282568
282,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Up,0.262139369233752,0.756909410282568
283,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.262402737699056,0.756909410282568
284,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.26240787439133,0.756909410282568
285,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Down,0.263526335464499,0.756909410282568
286,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.264386417403529,0.756909410282568
287,WP_FOCAL_ADHESION,121,Down,0.2655178225954,0.756909410282568
288,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.266984928830187,0.756909410282568
289,WP_OSTEOBLAST_SIGNALING,3,Down,0.267138127377007,0.756909410282568
290,WP_SERINE_METABOLISM,7,Up,0.267578416113403,0.756909410282568
291,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.267956981012442,0.756909410282568
292,WP_ACE_INHIBITOR_PATHWAY,5,Down,0.271447501231468,0.758394593148893
293,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.27175951738722,0.758394593148893
294,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.271840118482642,0.758394593148893
295,WP_TRANSSULFURATION_PATHWAY,8,Down,0.272409720098256,0.758394593148893
296,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.275702951534295,0.758394593148893
297,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,11,Down,0.276356188310786,0.758394593148893
298,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.276627583121914,0.758394593148893
299,WP_NRXN1_DELETION_SYNDROME,2,Down,0.277262174864912,0.758394593148893
300,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.277780960793828,0.758394593148893
301,WP_TAR_SYNDROME,44,Down,0.278098233372614,0.758394593148893
302,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,15,Up,0.280857279280631,0.758394593148893
303,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.281950671868568,0.758394593148893
304,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.282857439546857,0.758394593148893
305,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.283870984960493,0.758394593148893
306,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Down,0.283982585683307,0.758394593148893
307,WP_IL18_SIGNALING,192,Down,0.288252816833742,0.758394593148893
308,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.288427241064574,0.758394593148893
309,WP_METABOLIC_EPILEPTIC_DISORDERS,61,Up,0.289211867066295,0.758394593148893
310,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Up,0.289273725135237,0.758394593148893
311,WP_MELANOMA,54,Down,0.292811496461765,0.758394593148893
312,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,10,Down,0.295098443287174,0.758394593148893
313,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.295172589776242,0.758394593148893
314,WP_PEPTIDE_GPCRS,14,Up,0.295422610565162,0.758394593148893
315,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.295652759514685,0.758394593148893
316,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,29,Up,0.295851760390138,0.758394593148893
317,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.296108377564721,0.758394593148893
318,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Down,0.297571589956658,0.758394593148893
319,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,177,Down,0.297635973951124,0.758394593148893
320,WP_PURINERGIC_SIGNALING,16,Down,0.299297614795206,0.758394593148893
321,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,47,Up,0.299610462338758,0.758394593148893
322,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.300238123369998,0.758394593148893
323,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.300238123369998,0.758394593148893
324,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,73,Down,0.302188938143155,0.758394593148893
325,WP_TCELL_RECEPTOR_SIGNALING,73,Down,0.302389808461261,0.758394593148893
326,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.302418230484812,0.758394593148893
327,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Down,0.304457642423925,0.758394593148893
328,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Up,0.304507379398121,0.758394593148893
329,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,46,Down,0.305034387744674,0.758394593148893
330,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,44,Down,0.305485143369179,0.758394593148893
331,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Down,0.307426358790966,0.758394593148893
332,WP_OSTEOPONTIN_SIGNALING,11,Down,0.307948477840454,0.758394593148893
333,WP_GASTRIN_SIGNALING,94,Down,0.308103884352342,0.758394593148893
334,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.30815546728921,0.758394593148893
335,WP_TGFBETA_RECEPTOR_SIGNALING,36,Down,0.309524043743581,0.759093373879121
336,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.310716106057446,0.759093373879121
337,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Down,0.311209813865284,0.759093373879121
338,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.31271811686052,0.760134048292096
339,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,63,Up,0.313485939624112,0.760134048292096
340,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,27,Down,0.314502960741496,0.760357158027971
341,WP_TNFALPHA_SIGNALING,85,Down,0.316403142990105,0.762707869612512
342,WP_MESODERMAL_COMMITMENT_PATHWAY,77,Down,0.317572765498092,0.763288927600678
343,WP_NOTCH_SIGNALING_WP61,49,Down,0.319948007903622,0.764713196690983
344,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.320025960659,0.764713196690983
345,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.321755937534505,0.76661849464743
346,WP_GPCRS_CLASS_A_RHODOPSINLIKE,43,Down,0.324161733707663,0.770118338461559
347,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.325164129400338,0.770273528435384
348,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.327438527089323,0.771437938018746
349,WP_NEOVASCULARIZATION_PROCESSES,22,Down,0.327532652516475,0.771437938018746
350,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.330551921988076,0.773199214244772
351,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.330991918157969,0.773199214244772
352,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.331920746746484,0.773199214244772
353,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Up,0.332680410221137,0.773199214244772
354,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.332983603214902,0.773199214244772
355,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.335059927499275,0.774774349354762
356,WP_LEPTIN_SIGNALING,70,Down,0.336838383674664,0.774774349354762
357,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.336936952127975,0.774774349354762
358,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.337432137553534,0.774774349354762
359,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,5,Down,0.340023027619153,0.778548547919063
360,WP_HEPATITIS_B_INFECTION,119,Down,0.341554601033727,0.779883005693677
361,WP_KININKALLIKREIN_PATHWAY,2,Up,0.345986524918829,0.781385898704382
362,WP_DNA_REPLICATION,36,Up,0.34756215277646,0.781385898704382
363,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.347923560501825,0.781385898704382
364,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Up,0.348133901068023,0.781385898704382
365,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.348249838682752,0.781385898704382
366,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Down,0.348431174701251,0.781385898704382
367,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.351970408713964,0.781385898704382
368,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Down,0.352150848337451,0.781385898704382
369,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,46,Down,0.353729062212385,0.781385898704382
370,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,5,Down,0.354392450945867,0.781385898704382
371,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.354530917820302,0.781385898704382
372,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.354856559296828,0.781385898704382
373,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.355198420469031,0.781385898704382
374,WP_MONOAMINE_GPCRS,3,Up,0.35572267367672,0.781385898704382
375,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.357178010684101,0.781385898704382
376,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.357422260234608,0.781385898704382
377,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.362258940766556,0.78907279656199
378,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,13,Down,0.362858293309528,0.78907279656199
379,WP_COMPLEMENT_SYSTEM,52,Up,0.366551257006647,0.793293437314968
380,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.367617051662302,0.793293437314968
381,WP_CHOLESTASIS,9,Up,0.367694403427011,0.793293437314968
382,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Up,0.369107804276269,0.793911364336858
383,WP_NOTCH_SIGNALING_WP268,35,Down,0.370915194966484,0.793911364336858
384,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,62,Down,0.371250909385505,0.793911364336858
385,WP_PPARALPHA_PATHWAY,15,Down,0.372695618148918,0.793911364336858
386,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.372809959408792,0.793911364336858
387,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.374950782876799,0.796407089211185
388,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.376607142933752,0.797221926598619
389,WP_KLEEFSTRA_SYNDROME,25,Down,0.377274123414675,0.797221926598619
390,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.380692907599959,0.802340200270512
391,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,39,Down,0.381648440761277,0.802340200270512
392,WP_ANGIOGENESIS,14,Down,0.38480676819993,0.803412938151056
393,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.390402300751681,0.803412938151056
394,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,58,Up,0.390423225796789,0.803412938151056
395,WP_METASTATIC_BRAIN_TUMOR,5,Down,0.39067918581297,0.803412938151056
396,WP_SMALL_LIGAND_GPCRS,7,Up,0.390905925139527,0.803412938151056
397,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,12,Down,0.390937757519891,0.803412938151056
398,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,66,Down,0.391305363754544,0.803412938151056
399,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.39162620548448,0.803412938151056
400,WP_COMPLEMENT_ACTIVATION,12,Up,0.394586490851003,0.803412938151056
401,WP_SEROTONIN_AND_ANXIETY,8,Down,0.395104697861945,0.803412938151056
402,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.396498483976446,0.803412938151056
403,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.39698024895572,0.803412938151056
404,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Down,0.397259197479773,0.803412938151056
405,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,33,Down,0.397464001949469,0.803412938151056
406,WP_NUCLEAR_RECEPTORS,20,Down,0.398678718258387,0.803412938151056
407,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,4,Up,0.40002435430884,0.803412938151056
408,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.400401732070384,0.803412938151056
409,WP_ENDOMETRIAL_CANCER,49,Down,0.400904548827515,0.803412938151056
410,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,82,Down,0.401633399661813,0.803412938151056
411,WP_CILIOPATHIES,129,Up,0.401706469075528,0.803412938151056
412,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.40274019884569,0.803525348182421
413,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,17,Down,0.406784000357914,0.809435868523489
414,WP_NPHP1_DELETION_SYNDROME,10,Down,0.407672079767305,0.809435868523489
415,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,24,Down,0.412768224056523,0.817579470299908
416,WP_HIPPO_SIGNALING_REGULATION,45,Down,0.416518654484337,0.82140769855381
417,WP_GLUTATHIONE_METABOLISM,11,Down,0.416941692616561,0.82140769855381
418,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.417719292153568,0.82140769855381
419,WP_GALANIN_RECEPTOR_PATHWAY,10,Down,0.420018863926795,0.82140769855381
420,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,38,Down,0.420881421098787,0.82140769855381
421,WP_BLOOD_CLOTTING_CASCADE,6,Up,0.421647980415944,0.82140769855381
422,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.422844835776928,0.82140769855381
423,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Down,0.423176737346573,0.82140769855381
424,WP_VEGFAVEGFR2_SIGNALING,344,Down,0.423694481979094,0.82140769855381
425,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Up,0.426514153301795,0.824928550621353
426,WP_SILDENAFIL_TREATMENT,11,Down,0.42922831671327,0.827537149929276
427,WP_AMINO_ACID_METABOLISM,59,Up,0.431361875926538,0.827537149929276
428,WP_TRANSLATION_FACTORS,49,Down,0.432875015013005,0.827537149929276
429,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.43421664872073,0.827537149929276
430,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.438381842203665,0.827537149929276
431,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Up,0.439592009234339,0.827537149929276
432,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,31,Down,0.439994246821399,0.827537149929276
433,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.441451315851251,0.827537149929276
434,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.442408713678464,0.827537149929276
435,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.443080721685828,0.827537149929276
436,WP_CELLULAR_PROTEOSTASIS,6,Up,0.443640783217994,0.827537149929276
437,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,33,Down,0.444051053554262,0.827537149929276
438,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Up,0.444260808156146,0.827537149929276
439,WP_ENERGY_METABOLISM,41,Down,0.444353067630762,0.827537149929276
440,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.445294019719952,0.827537149929276
441,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.446907506293031,0.827537149929276
442,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Down,0.447682930438577,0.827537149929276
443,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.448321916170776,0.827537149929276
444,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Up,0.449895732262372,0.827537149929276
445,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.449912614247983,0.827537149929276
446,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.451502944416578,0.827537149929276
447,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Down,0.451544063441477,0.827537149929276
448,WP_TYPE_II_INTERFERON_SIGNALING,30,Up,0.456053428150081,0.827537149929276
449,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.457741801472857,0.827537149929276
450,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Down,0.458016167916481,0.827537149929276
451,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.459796138516463,0.827537149929276
452,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,74,Down,0.46111771542231,0.827537149929276
453,WP_BDNFTRKB_SIGNALING,27,Down,0.461709775766311,0.827537149929276
454,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,19,Up,0.462871549096657,0.827537149929276
455,WP_HUNGER_AND_SATIETY,2,Up,0.462929832205019,0.827537149929276
456,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.463893756893703,0.827537149929276
457,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.463893756893703,0.827537149929276
458,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.464263053595352,0.827537149929276
459,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.465170756849581,0.827537149929276
460,WP_15Q11Q13_COPY_NUMBER_VARIATION,36,Up,0.465440817666791,0.827537149929276
461,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.465862851688035,0.827537149929276
462,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.466265047701848,0.827537149929276
463,WP_AUTOPHAGY,27,Down,0.466271406605756,0.827537149929276
464,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.468686533555639,0.827537149929276
465,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.470501002895883,0.827537149929276
466,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.470978763521871,0.827537149929276
467,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.472025566358189,0.827537149929276
468,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.472179868357937,0.827537149929276
469,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.473053077743734,0.827537149929276
470,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,62,Down,0.473836700017089,0.827537149929276
471,WP_AGERAGE_PATHWAY,54,Down,0.474172746492322,0.827537149929276
472,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.47713069081781,0.830935228500507
473,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,0.479788339186938,0.833797071483431
474,WP_RAS_SIGNALING,119,Down,0.48259375192217,0.836702055987731
475,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.484313390014312,0.836702055987731
476,WP_ESTROGEN_METABOLISM_WP697,6,Up,0.486244760329756,0.836702055987731
477,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.487434464851124,0.836702055987731
478,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.487533965428734,0.836702055987731
479,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.487567256469736,0.836702055987731
480,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Down,0.490488474999222,0.839129355464239
481,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.491023381968734,0.839129355464239
482,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Down,0.495630417020017,0.839135989547804
483,WP_RETINOBLASTOMA_GENE_IN_CANCER,74,Up,0.498563918388456,0.839135989547804
484,WP_IDO_METABOLIC_PATHWAY,7,Down,0.498886585969684,0.839135989547804
485,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.498969063586463,0.839135989547804
486,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.499635502881209,0.839135989547804
487,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Down,0.501201369607709,0.839135989547804
488,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.501782648658862,0.839135989547804
489,WP_BASE_EXCISION_REPAIR,29,Up,0.502998406115817,0.839135989547804
490,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.503323754195739,0.839135989547804
491,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.503568829659328,0.839135989547804
492,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,0.505798473119567,0.839135989547804
493,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,18,Down,0.505873641404468,0.839135989547804
494,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Down,0.505933006608988,0.839135989547804
495,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.507420273902016,0.839135989547804
496,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,169,Down,0.509232266341139,0.839135989547804
497,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.509446919154892,0.839135989547804
498,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.510329161015273,0.839135989547804
499,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Down,0.5111585891337,0.839135989547804
500,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.511159410794282,0.839135989547804
501,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Down,0.511444198009063,0.839135989547804
502,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.516396791303217,0.845574028787339
503,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Up,0.518880692780017,0.84631998416522
504,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.518911523137799,0.84631998416522
505,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,137,Down,0.52119718291171,0.84836452347213
506,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.525248196793177,0.853268809810261
507,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.526497410722855,0.853611186615753
508,WP_IL3_SIGNALING,46,Down,0.531407760494514,0.854840799735076
509,WP_PDGFRBETA_PATHWAY,28,Down,0.532612385790332,0.854840799735076
510,WP_PROTEASOME_DEGRADATION,57,Up,0.533139093652104,0.854840799735076
511,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,14,Up,0.534145921544533,0.854840799735076
512,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.534204150737086,0.854840799735076
513,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Down,0.534349005074656,0.854840799735076
514,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.534535487912201,0.854840799735076
515,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.539937518824814,0.861803185386403
516,WP_CELL_CYCLE,96,Up,0.541170000526231,0.862096396187135
517,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.542491235601347,0.862529585424193
518,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.545560459021983,0.864502564211567
519,WP_WNT_SIGNALING_AND_PLURIPOTENCY,61,Up,0.545835560615332,0.864502564211567
520,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.549257465135345,0.868249300656256
521,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,80,Down,0.553245572539109,0.872874972412951
522,WP_TP53_NETWORK,16,Down,0.556763175687014,0.876033563029197
523,WP_5Q35_COPY_NUMBER_VARIATION,78,Up,0.55737901881298,0.876033563029197
524,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.56150833046605,0.880839403899033
525,WP_DNA_DAMAGE_RESPONSE,58,Up,0.566228131214713,0.884746358305412
526,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.566742710753455,0.884746358305412
527,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.568494876086611,0.884746358305412
528,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.570517052696164,0.884746358305412
529,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.570945468803945,0.884746358305412
530,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,12,Up,0.57197930074901,0.884746358305412
531,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.57239965820229,0.884746358305412
532,WP_NUCLEOTIDE_GPCRS,6,Down,0.572609565229293,0.884746358305412
533,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.575692583238875,0.886514455848874
534,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.575910850879926,0.886514455848874
535,WP_IL5_SIGNALING,37,Down,0.578773930080121,0.889256393506279
536,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Down,0.580687911658948,0.890532580939655
537,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.583165500555665,0.892666743867331
538,WP_THERMOGENESIS,74,Down,0.586198393725444,0.895641411974563
539,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Down,0.588802720838978,0.897951459238663
540,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.59410485299371,0.9011302535968
541,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.596222770349761,0.9011302535968
542,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.596489274735335,0.9011302535968
543,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.597180401465652,0.9011302535968
544,WP_NONSMALL_CELL_LUNG_CANCER,60,Down,0.597319752705701,0.9011302535968
545,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.598677342670359,0.9011302535968
546,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,0.60058562136646,0.9011302535968
547,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Down,0.601587684294182,0.9011302535968
548,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.603045214939708,0.9011302535968
549,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Down,0.603378003923002,0.9011302535968
550,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Up,0.603950319590248,0.9011302535968
551,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.604674643597926,0.9011302535968
552,WP_DOPAMINERGIC_NEUROGENESIS,4,Down,0.605138564459165,0.9011302535968
553,WP_UROTENSINIIMEDIATED_SIGNALING,49,Down,0.606359011133297,0.901314841142079
554,WP_FOXP3_IN_COVID19,9,Down,0.608090175480915,0.902256541959048
555,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.61035799147571,0.903448355634282
556,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.611091588482556,0.903448355634282
557,WP_HEART_DEVELOPMENT,17,Down,0.612796331169077,0.904342161976627
558,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.615891187439004,0.907280566442403
559,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,17,Up,0.618062220791414,0.908849991932992
560,WP_FOXA2_PATHWAY,10,Down,0.620277282822299,0.910478440142731
561,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,48,Up,0.628525305182107,0.920940821496778
562,WP_SPINA_BIFIDA,10,Down,0.631796715512024,0.923216509913963
563,WP_G1_TO_S_CELL_CYCLE_CONTROL,51,Up,0.632324689880245,0.923216509913963
564,WP_PYRIMIDINE_METABOLISM,73,Down,0.637598638007593,0.925677754685262
565,WP_PRIMARY_OVARIAN_INSUFFICIENCY,90,Up,0.637710692500844,0.925677754685262
566,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.638124738207038,0.925677754685262
567,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Down,0.640131982248842,0.925677754685262
568,WP_VITAMIN_D_RECEPTOR_PATHWAY,86,Down,0.641555807838922,0.925677754685262
569,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.642363301490376,0.925677754685262
570,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,15,Up,0.643669655845774,0.925677754685262
571,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.645311480943944,0.925677754685262
572,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,15,Down,0.645348621253328,0.925677754685262
573,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.645465926495176,0.925677754685262
574,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.647302816214755,0.925677754685262
575,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Up,0.64752397681755,0.925677754685262
576,WP_TARGET_OF_RAPAMYCIN_SIGNALING,33,Down,0.650694534265361,0.926384610362325
577,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,48,Down,0.650992439160572,0.926384610362325
578,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.651622843354317,0.926384610362325
579,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.652745795176962,0.926384610362325
580,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.65365337470821,0.926384610362325
581,WP_CILIARY_LANDSCAPE,186,Up,0.656292633877467,0.928524173919584
582,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Down,0.659476478076166,0.930510692877816
583,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Down,0.660041609242744,0.930510692877816
584,WP_ENDOTHELIN_PATHWAYS,12,Down,0.662128466104595,0.930510692877816
585,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.662224763179468,0.930510692877816
586,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.66344733897404,0.930637734874847
587,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.667086855523414,0.93343236032806
588,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.66958413846886,0.93343236032806
589,WP_PRION_DISEASE_PATHWAY,28,Down,0.669898280501893,0.93343236032806
590,WP_IL2_SIGNALING,37,Down,0.669995170254286,0.93343236032806
591,WP_OPIOID_RECEPTOR_PATHWAYS,25,Down,0.671117426951196,0.93343236032806
592,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.674441987410846,0.93647181360087
593,WP_WNT_SIGNALING_WP428,60,Down,0.679096837428437,0.93998639443333
594,WP_13Q1212_COPY_NUMBER_VARIATION,20,Up,0.681149382059413,0.93998639443333
595,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,59,Up,0.68289650643509,0.93998639443333
596,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Down,0.683053633183889,0.93998639443333
597,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.684076427331064,0.93998639443333
598,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Down,0.684977920031101,0.93998639443333
599,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Down,0.684977920031101,0.93998639443333
600,WP_FATTY_ACID_BETAOXIDATION,29,Up,0.690468424874777,0.945000916938191
601,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Down,0.690931327347753,0.945000916938191
602,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.69325536866738,0.945688850669112
603,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Down,0.695185406398988,0.945688850669112
604,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,62,Up,0.696033613378042,0.945688850669112
605,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.696036197876901,0.945688850669112
606,WP_NAD_BIOSYNTHETIC_PATHWAYS,19,Up,0.699025692125687,0.946454503185951
607,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,11,Up,0.699965861432248,0.946454503185951
608,WP_CAMKK2_PATHWAY,30,Down,0.701747360428465,0.946454503185951
609,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.705398189467777,0.946454503185951
610,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Up,0.705442852765812,0.946454503185951
611,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,22,Down,0.705910575244771,0.946454503185951
612,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.706407034638351,0.946454503185951
613,WP_CORI_CYCLE,12,Down,0.707728847929536,0.946454503185951
614,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.709214344583627,0.946454503185951
615,WP_NEPHROTIC_SYNDROME,27,Down,0.709878255675322,0.946454503185951
616,WP_ALSTROM_SYNDROME,27,Up,0.709908214434589,0.946454503185951
617,WP_IL19_SIGNALING,20,Up,0.710607818740119,0.946454503185951
618,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.711567984147102,0.946454503185951
619,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.71461242615771,0.946760873757211
620,WP_FLUOROPYRIMIDINE_ACTIVITY,26,Up,0.714726223022656,0.946760873757211
621,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.717169615820438,0.946760873757211
622,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,25,Down,0.717377251325132,0.946760873757211
623,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.717557207239346,0.946760873757211
624,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.720847661391402,0.948690402423777
625,WP_LIPID_PARTICLES_COMPOSITION,6,Up,0.721327860723674,0.948690402423777
626,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.723799860566676,0.949394237266508
627,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.724172976601095,0.949394237266508
628,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.726298981130665,0.94957611278794
629,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,52,Down,0.726622110637,0.94957611278794
630,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,25,Down,0.733589311305088,0.956117342717046
631,WP_WNT_SIGNALING_WP363,38,Down,0.733953823910531,0.956117342717046
632,WP_IRON_METABOLISM_DISORDERS,10,Up,0.736743627737053,0.956222130619702
633,WP_DISORDERS_IN_KETOLYSIS,4,Up,0.737732516592394,0.956222130619702
634,WP_CHOLESTEROL_METABOLISM,54,Down,0.737740041663837,0.956222130619702
635,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,48,Up,0.738687412340038,0.956222130619702
636,WP_MRNA_PROCESSING,124,Down,0.741310981649732,0.957073642563193
637,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,126,Up,0.741673856828168,0.957073642563193
638,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,30,Down,0.74441843448482,0.958254627828884
639,WP_G_PROTEIN_SIGNALING,62,Down,0.747781623254166,0.958254627828884
640,WP_IL4_SIGNALING,51,Down,0.747809570042394,0.958254627828884
641,WP_MALE_INFERTILITY,71,Down,0.747919121621808,0.958254627828884
642,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.74841784801234,0.958254627828884
643,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.751666929388025,0.960917909730881
644,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.75731679646674,0.962098635140712
645,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.757373560303545,0.962098635140712
646,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.757853246361317,0.962098635140712
647,WP_ALZHEIMERS_DISEASE,185,Up,0.75844271967297,0.962098635140712
648,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,185,Up,0.75844271967297,0.962098635140712
649,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,93,Down,0.759723093084913,0.962237877528195
650,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.761261917959423,0.962703533173302
651,WP_HISTONE_MODIFICATIONS,37,Up,0.764127800571535,0.963174846496472
652,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,42,Up,0.766681206210055,0.963174846496472
653,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.76719853676077,0.963174846496472
654,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.769150317787247,0.963174846496472
655,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.770073200155114,0.963174846496472
656,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.770738877073507,0.963174846496472
657,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.772009801404094,0.963174846496472
658,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,9,Up,0.775103413458015,0.963174846496472
659,WP_ATR_SIGNALING,10,Up,0.776671668567466,0.963174846496472
660,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Down,0.781231440144603,0.963174846496472
661,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Down,0.781747867684643,0.963174846496472
662,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,52,Down,0.782549735981162,0.963174846496472
663,WP_ENDODERM_DIFFERENTIATION,84,Down,0.782692273931124,0.963174846496472
664,WP_AEROBIC_GLYCOLYSIS,10,Up,0.784618856016982,0.963174846496472
665,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.7858629242924,0.963174846496472
666,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,78,Up,0.787816770721572,0.963174846496472
667,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.788814549616424,0.963174846496472
668,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Up,0.789615378279561,0.963174846496472
669,WP_CCL18_SIGNALING,21,Down,0.790259872544756,0.963174846496472
670,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.790413315042514,0.963174846496472
671,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,11,Up,0.790488773683863,0.963174846496472
672,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,70,Down,0.791552223196338,0.963174846496472
673,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.792181214518206,0.963174846496472
674,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,29,Down,0.792348222205493,0.963174846496472
675,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.792653508787789,0.963174846496472
676,WP_KALLMANN_SYNDROME,11,Up,0.794994174296777,0.963174846496472
677,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,11,Up,0.795153086060549,0.963174846496472
678,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.796828043124071,0.963174846496472
679,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.797749385123991,0.963174846496472
680,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.798449736619233,0.963174846496472
681,WP_4P163_COPY_NUMBER_VARIATION,22,Up,0.798990820213066,0.963174846496472
682,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.800272822072266,0.963174846496472
683,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.800986893881519,0.963174846496472
684,WP_CIRCADIAN_RHYTHM_GENES,122,Down,0.801473959858378,0.963174846496472
685,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Down,0.805059039310578,0.965172570892873
686,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.806782846358517,0.965172570892873
687,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,36,Down,0.807230265225203,0.965172570892873
688,WP_IL17_SIGNALING,25,Down,0.808583397536271,0.965172570892873
689,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Up,0.809007179252055,0.965172570892873
690,WP_UREA_CYCLE_AND_RELATED_DISEASES,4,Down,0.810791359492841,0.9653004602781
691,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.812616297352628,0.9653004602781
692,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Down,0.812637370453096,0.9653004602781
693,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.816733813479765,0.968602221653521
694,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.817773651858325,0.968602221653521
695,WP_RAC1PAK1P38MMP2_PATHWAY,52,Down,0.819222630131122,0.968922304989615
696,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.824340957516493,0.97327964842279
697,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Up,0.825274835706429,0.97327964842279
698,WP_IL11_SIGNALING,41,Up,0.827252268836903,0.97421398994833
699,WP_IRINOTECAN_PATHWAY,5,Up,0.829969744966806,0.976015923265685
700,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.834315661279729,0.978391579185792
701,WP_IL9_SIGNALING,15,Up,0.834370434317811,0.978391579185792
702,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,49,Down,0.835825972389699,0.978641313705302
703,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Up,0.836964529847722,0.978641313705302
704,WP_ECTODERM_DIFFERENTIATION,78,Up,0.840514962798202,0.97938716227473
705,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,20,Down,0.840860413901079,0.97938716227473
706,WP_AFLATOXIN_B1_METABOLISM,3,Down,0.843186231310486,0.97938716227473
707,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.845036334670004,0.97938716227473
708,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,76,Up,0.84557000446499,0.97938716227473
709,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,29,Up,0.848623633319134,0.97938716227473
710,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Up,0.849020139718039,0.97938716227473
711,WP_TRYPTOPHAN_METABOLISM,18,Up,0.850116957293343,0.97938716227473
712,WP_VALPROIC_ACID_PATHWAY,9,Up,0.851192498789597,0.97938716227473
713,WP_ULCERATIVE_COLITIS_SIGNALING,12,Down,0.85129075259497,0.97938716227473
714,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Down,0.853383456493171,0.97938716227473
715,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,52,Up,0.85353629351201,0.97938716227473
716,WP_CYTOSOLIC_DNASENSING_PATHWAY,54,Down,0.853935481621373,0.97938716227473
717,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.857452515857422,0.97938716227473
718,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.860280872294678,0.97938716227473
719,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Up,0.860603092271028,0.97938716227473
720,WP_BREAST_CANCER_PATHWAY,87,Down,0.861045580922764,0.97938716227473
721,WP_SELENIUM_MICRONUTRIENT_NETWORK,51,Down,0.865690094532496,0.97938716227473
722,WP_P38_MAPK_SIGNALING,31,Down,0.865796202325313,0.97938716227473
723,WP_VITAMIN_D_METABOLISM,6,Down,0.866089042333729,0.97938716227473
724,WP_NEPHROGENESIS,4,Down,0.867347158691771,0.97938716227473
725,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Down,0.867623977704745,0.97938716227473
726,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Down,0.868141323241914,0.97938716227473
727,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.869244311077656,0.97938716227473
728,WP_FERROPTOSIS,51,Down,0.869352721084869,0.97938716227473
729,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,42,Up,0.871174444926472,0.97938716227473
730,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.873608138752995,0.97938716227473
731,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,8,Down,0.875178997429518,0.97938716227473
732,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,13,Down,0.875958175497942,0.97938716227473
733,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,41,Up,0.876225521626991,0.97938716227473
734,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Up,0.879343465483487,0.97938716227473
735,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.879374118857226,0.97938716227473
736,WP_CANCER_PATHWAYS,311,Up,0.881537177856982,0.97938716227473
737,WP_VITAMIN_B12_DISORDERS,9,Up,0.881652377165271,0.97938716227473
738,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.881815601497223,0.97938716227473
739,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.882676371394168,0.97938716227473
740,WP_OSTEOCLAST_SIGNALING,9,Down,0.885177191561468,0.97938716227473
741,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,16,Up,0.885581132252308,0.97938716227473
742,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.887071556028895,0.97938716227473
743,WP_DNA_MISMATCH_REPAIR,21,Down,0.887242226311508,0.97938716227473
744,WP_ACUTE_MYELOID_LEUKEMIA,56,Down,0.888377792978688,0.97938716227473
745,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Up,0.891198498419032,0.97938716227473
746,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.892372920773658,0.97938716227473
747,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.894037079584403,0.97938716227473
748,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.898234637563926,0.97938716227473
749,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.898465362702203,0.97938716227473
750,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Down,0.898941560475666,0.97938716227473
751,WP_PREIMPLANTATION_EMBRYO,21,Up,0.899215773979977,0.97938716227473
752,WP_TGFB_SMAD_SIGNALING,7,Up,0.899776957108064,0.97938716227473
753,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.901271064526362,0.97938716227473
754,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Up,0.901501114743133,0.97938716227473
755,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,63,Up,0.901515629083342,0.97938716227473
756,WP_HIPPOYAP_SIGNALING,16,Down,0.903041370845347,0.97938716227473
757,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.904533078297581,0.97938716227473
758,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Down,0.905213613246337,0.97938716227473
759,WP_INTEGRATED_CANCER_PATHWAY,41,Down,0.905349848734501,0.97938716227473
760,WP_PI3KAKT_SIGNALING,180,Down,0.905516111105589,0.97938716227473
761,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.912154208492714,0.983069843283682
762,WP_ATM_SIGNALING,34,Down,0.914042012839511,0.983069843283682
763,WP_CYTOSINE_METHYLATION,7,Down,0.914691536232461,0.983069843283682
764,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.915051794389802,0.983069843283682
765,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.915201237977697,0.983069843283682
766,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.91826323217497,0.983069843283682
767,WP_ACUTE_VIRAL_MYOCARDITIS,65,Up,0.919287211497302,0.983069843283682
768,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.920671898096189,0.983069843283682
769,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.921435365858705,0.983069843283682
770,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.921774007365197,0.983069843283682
771,WP_BARDETBIEDL_SYNDROME,65,Up,0.922076458846373,0.983069843283682
772,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Up,0.925641864605335,0.985592762572002
773,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.92886032160575,0.987740212626037
774,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.931935203065873,0.989729634263757
775,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.935135012349599,0.990624821570066
776,WP_MEVALONATE_PATHWAY,7,Up,0.935188396032082,0.990624821570066
777,WP_TCELL_ACTIVATION_SARSCOV2,63,Down,0.945528249367111,0.99354992079652
778,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Up,0.94566041820833,0.99354992079652
779,WP_NUCLEAR_RECEPTORS_METAPATHWAY,180,Down,0.946127723087455,0.99354992079652
780,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,72,Up,0.946238721977993,0.99354992079652
781,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Up,0.947887982720945,0.99354992079652
782,WP_APOPTOSIS_MODULATION_AND_SIGNALING,79,Down,0.951286141896373,0.99354992079652
783,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,89,Down,0.952172207423911,0.99354992079652
784,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.953919782544116,0.99354992079652
785,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.954141859075714,0.99354992079652
786,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.954167137578432,0.99354992079652
787,WP_HEME_BIOSYNTHESIS,8,Up,0.954167137578432,0.99354992079652
788,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.957609311262887,0.99354992079652
789,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Down,0.957741136249837,0.99354992079652
790,WP_IL7_SIGNALING,23,Up,0.959569463723822,0.99354992079652
791,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,278,Up,0.960113002244516,0.99354992079652
792,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.960230390994363,0.99354992079652
793,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.961257392989413,0.99354992079652
794,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.962183991107947,0.99354992079652
795,WP_IL6_SIGNALING,38,Down,0.962550944339195,0.99354992079652
796,WP_SPHINGOLIPID_PATHWAY,20,Down,0.963164351160368,0.99354992079652
797,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,12,Up,0.964771045407555,0.99354992079652
798,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.966660946829976,0.99354992079652
799,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Up,0.966993991967874,0.99354992079652
800,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,13,Up,0.96944977085473,0.99354992079652
801,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Down,0.971882964224575,0.99354992079652
802,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Up,0.973087544724285,0.99354992079652
803,WP_OXIDATION_BY_CYTOCHROME_P450,15,Up,0.973815780900205,0.99354992079652
804,WP_16P112_DISTAL_DELETION_SYNDROME,22,Up,0.977248670848509,0.99354992079652
805,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Up,0.977366724037202,0.99354992079652
806,WP_ESTROGEN_SIGNALING,21,Up,0.977835225781712,0.99354992079652
807,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,4,Up,0.978235176992639,0.99354992079652
808,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.979388615507597,0.99354992079652
809,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Down,0.979806389494,0.99354992079652
810,WP_PPAR_SIGNALING,39,Up,0.97983342513608,0.99354992079652
811,WP_GLYCOLYSIS_IN_SENESCENCE,11,Up,0.980850675851999,0.99354992079652
812,WP_APOPTOSIS,73,Down,0.982548254295041,0.99354992079652
813,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.983838636827811,0.99354992079652
814,WP_MTHFR_DEFICIENCY,18,Down,0.984119748579942,0.99354992079652
815,WP_ONECARBON_METABOLISM,23,Up,0.985679408619208,0.99354992079652
816,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.986297731593626,0.99354992079652
817,WP_STEROID_BIOSYNTHESIS,3,Down,0.989275785165987,0.994798689822293
818,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,24,Up,0.989957820285445,0.994798689822293
819,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.992925165575892,0.996191479724867
820,WP_FRAGILE_X_SYNDROME,84,Up,0.993767656173224,0.996191479724867
821,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Up,0.99880078817431,0.998895192909457
822,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.998895192909457,0.998895192909457
